20,653 Shares in Concentrix Corporation $CNXC Acquired by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company purchased a new position in shares of Concentrix Corporation (NASDAQ:CNXC) during the 2nd quarter, HoldingsChannel.com reports. The institutional investor purchased 20,653 shares of the company’s stock, valued at approximately $463,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Royal Bank of Canada grew its position in shares of Concentrix by 9.5% during the first quarter. Royal Bank of Canada now owns 47,501 shares of the company’s stock worth $2,643,000 after acquiring an additional 4,133 shares during the last quarter. Goldman Sachs Group Inc. increased its holdings in shares of Concentrix by 75.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company’s stock valued at $23,552,000 after acquiring an additional 181,546 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Concentrix by 17.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company’s stock valued at $8,152,000 after purchasing an additional 21,746 shares during the last quarter. Focus Partners Wealth acquired a new stake in Concentrix during the 1st quarter worth $781,000. Finally, Geneos Wealth Management Inc. boosted its stake in Concentrix by 532.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after purchasing an additional 522 shares during the period. Hedge funds and other institutional investors own 90.34% of the company’s stock.

Concentrix Price Performance

Shares of Concentrix stock opened at $32.16 on Monday. The company has a market cap of $1.96 billion, a P/E ratio of -1.51, a PEG ratio of 0.59 and a beta of 0.47. The company has a debt-to-equity ratio of 1.46, a quick ratio of 1.18 and a current ratio of 1.18. Concentrix Corporation has a one year low of $19.12 and a one year high of $57.88. The firm has a fifty day moving average of $25.41 and a two-hundred day moving average of $27.03.

Concentrix (NASDAQ:CNXC) last issued its earnings results on Monday, June 29th. The company reported $2.63 earnings per share for the quarter, missing the consensus estimate of $2.64 by ($0.01). Concentrix had a negative net margin of 13.16% and a positive return on equity of 19.82%. The firm had revenue of $2.46 billion during the quarter, compared to analysts’ expectations of $2.47 billion. During the same period in the previous year, the firm earned $2.70 EPS. The firm’s revenue was up 1.9% on a year-over-year basis. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. On average, analysts forecast that Concentrix Corporation will post 9.67 earnings per share for the current year.

Concentrix Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, August 4th. Investors of record on Friday, July 24th were given a $0.36 dividend. The ex-dividend date was Friday, July 24th. This represents a $1.44 dividend on an annualized basis and a yield of 4.5%. Concentrix’s dividend payout ratio (DPR) is presently -6.75%.

Analysts Set New Price Targets

Several brokerages have issued reports on CNXC. Robert W. Baird lowered their price objective on shares of Concentrix from $40.00 to $30.00 and set an “outperform” rating on the stock in a research report on Tuesday, June 30th. Zacks Research raised Concentrix from a “strong sell” rating to a “hold” rating in a report on Monday, August 31st. Canaccord Genuity Group dropped their price target on Concentrix from $55.00 to $45.00 and set a “buy” rating on the stock in a research report on Tuesday, June 30th. Barrington Research reduced their price objective on Concentrix from $38.00 to $30.00 and set an “outperform” rating for the company in a research note on Tuesday, June 30th. Finally, Bank of America decreased their price objective on Concentrix from $32.00 to $26.00 and set a “neutral” rating for the company in a research report on Tuesday, June 30th. Three analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $32.75.

Concentrix Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.